KOSPI vs KOSDAQ — What Actually Separates Korea's Two Boards

Korea runs two boards. Foreign investors often treat them as one market with a size split, which misses what actually separates them — different listing requirements attract different kinds of business, and the valuation gap follows from that.

1. The numbers

KOSDAQ has more than twice as many listings, but the market-cap weight runs the other way: the ten largest companies in Korea — almost all KOSPI names — account for 56.6% of total market value.

2. Why the P/B gap is structural

KOSPI opened in 1956 and applies higher size and earnings requirements. It is where the manufacturing incumbents sit — semiconductors, autos, steel, chemicals, banks, telecoms. These businesses own factories, fabs, fleets and branch networks. Tangible assets are thick, so book value is large and P/B is mechanically low.

KOSDAQ opened in 1996 for growth companies and admits businesses that do not yet earn much, via technology-based listing routes. Biotech, software, components and equipment dominate. Their core assets — code, clinical pipelines, engineering teams — are not capitalised on the balance sheet at all, so book value is small and P/B is mechanically high.

Neither number tells you which board is "cheaper." They are measuring different kinds of company with the same ruler.

3. The P/E gap is smaller than it looks — because of who is missing

12.4x versus 14.1x looks modest, but remember that a P/E only exists for a profitable company. Across the whole market 37.8% of companies have negative returns, and those names are concentrated in the sectors that populate KOSDAQ — pharma/biotech (83 loss-makers of 181), software and games (77 of 157), R&D services (59 of 67).

So the KOSDAQ median P/E is computed on a survivor set. It describes the profitable minority, not the board. Any cross-board comparison on P/E alone is comparing different populations.

4. Rules that matter to a foreign investor

Delisting risk is higher on KOSDAQ. Korea runs a "administrative issue" designation and a separate substantive listing-eligibility review. Triggers include sustained operating losses, capital impairment, audit opinions other than unqualified, and disclosure violations. A company can be suspended from trading while under review — a risk that has no close analogue in most developed markets.

Check the audit opinion first. Anything other than an unqualified opinion is a much stronger signal than any valuation multiple. It appears in the audit report attached to the annual filing.

Liquidity is thin below the top names. Median market cap across the whole market is ₩100.8bn (about US$71m). Screening on multiples without checking traded value produces a list of companies you cannot actually buy or sell in size.

Key figures

• KOSPI 834 companies, median P/E 12.4x, median P/B 0.61x.
• KOSDAQ 1,819 companies, median P/E 14.1x, median P/B 1.01x.
• The P/B gap reflects tangible-asset intensity, not relative cheapness.
• Loss-makers cluster on KOSDAQ, so its P/E median describes a survivor set.